| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/BACT.1.4.17747 |
| P8608 | Fatcat ID | release_v3j6zpii4nc4jofmwxfiocedoy |
| P932 | PMC publication ID | 3448103 |
| P698 | PubMed publication ID | 23050211 |
| P5875 | ResearchGate publication ID | 232227299 |
| P2093 | author name string | Vincent A Fischetti | |
| P2860 | cites work | Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium | Q24563225 |
| Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme | Q24609957 | ||
| Bacteriophage lysis: mechanism and regulation | Q24634690 | ||
| Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages | Q24655430 | ||
| Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia | Q24671527 | ||
| Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1 | Q27642277 | ||
| The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis | Q27643380 | ||
| Holins: the protein clocks of bacteriophage infections | Q28140369 | ||
| Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity | Q28144392 | ||
| C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates | Q28215660 | ||
| Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages | Q28278525 | ||
| The crystal structure of the bacteriophage PSA endolysin reveals a unique fold responsible for specific recognition of Listeria cell walls | Q30159623 | ||
| An historical antecedent of modern guidelines for community pandemic influenza mitigation | Q30376726 | ||
| Peptidoglycan hydrolase fusions maintain their parental specificities | Q30446323 | ||
| Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group | Q31797996 | ||
| Rapid DNA library construction for functional genomic and metagenomic screening | Q33310580 | ||
| Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus | Q33525230 | ||
| Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme | Q33555987 | ||
| Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes | Q33851733 | ||
| The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus | Q34077249 | ||
| Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats | Q34123647 | ||
| A bacteriolytic agent that detects and kills Bacillus anthracis | Q34145707 | ||
| Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases | Q34463971 | ||
| LysGH15, a Novel Bacteriophage Lysin, Protects a Murine Bacteremia Model Efficiently against Lethal Methicillin-Resistant Staphylococcus aureus Infection | Q34487554 | ||
| PlyC: a multimeric bacteriophage lysin | Q34708961 | ||
| Biological function of the dTDP-rhamnose synthesis pathway in Streptococcus mutans | Q35619876 | ||
| Bacteriophage endolysins--current state of research and applications | Q36175326 | ||
| LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae | Q36313687 | ||
| Staphylococcal bacteriophage-associated lysin: a lytic agent active against Staphylococcus aureus | Q36773346 | ||
| Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli | Q38346480 | ||
| Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal. | Q39508225 | ||
| Sizing the holin lesion with an endolysin-beta-galactosidase fusion | Q39705803 | ||
| Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains | Q39730777 | ||
| Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol | Q39740458 | ||
| The pneumococcal cell wall degrading enzymes: a modular design to create new lysins? | Q41499347 | ||
| Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance | Q41816188 | ||
| Lytic enzyme discovery through multigenomic sequence analysis in Clostridium perfringens. | Q41960252 | ||
| Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. | Q42121862 | ||
| Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. | Q43511826 | ||
| Structural analysis and biological significance of the cell wall lytic enzymes of Streptococcus pneumoniae and its bacteriophage | Q43595867 | ||
| What really happened during the 1918 influenza pandemic? The importance of bacterial secondary infections | Q43689050 | ||
| Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase | Q43820230 | ||
| Characterization of staphylococcal -lysin | Q45149798 | ||
| Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. | Q45172053 | ||
| Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria | Q45720461 | ||
| Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis | Q46602101 | ||
| Structure and lytic activity of a Bacillus anthracis prophage endolysin | Q46639780 | ||
| Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. | Q46936223 | ||
| Inhibition of lysis by antibody against phage-associated lysin and requirement of choline residues in the cell wall for progeny phage release inStreptococcus pneumoniae | Q57077303 | ||
| Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients | Q72387190 | ||
| Phages will out: strategies of host cell lysis | Q73521363 | ||
| Surface diffusion of cellulases and their isolated binding domains on cellulose | Q73692349 | ||
| A protein antibiotic in the phage Qbeta virion: diversity in lysis targets | Q74087194 | ||
| Group A Streptococcus carriage among close contacts of patients with invasive infections | Q77377706 | ||
| P433 | issue | 4 | |
| P921 | main subject | gram-positive bacteria | Q857288 |
| P304 | page(s) | 188-194 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Bacteriophage | Q26842056 |
| P1476 | title | Exploiting what phage have evolved to control gram-positive pathogens | |
| P478 | volume | 1 |
| Q38165668 | Antibacterial bioagents based on principles of bacteriophage biology: an overview |
| Q34017160 | Bacteriophage-based synthetic biology for the study of infectious diseases. |
| Q40107071 | Bam35 tectivirus intraviral interaction map unveils new function and localization of phage ORFan proteins. |
| Q36434131 | Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus |
| Q92377206 | Contributions of Net Charge on the PlyC Endolysin CHAP Domain |
| Q39617629 | Disclosing early steps of protein-primed genome replication of the Gram-positive tectivirus Bam35. |
| Q26744156 | Genetically Engineered Phages: a Review of Advances over the Last Decade |
| Q38827899 | Modeling intraocular bacterial infections |
| Q39531958 | Models for the directed evolution of bacterial allelopathy: bacteriophage lysins |
| Q36110304 | Mycobacteriophage cell binding proteins for the capture of mycobacteria |
| Q35168859 | Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model |
| Q92172572 | Optimized production of a biologically active Clostridium perfringens glycosyl hydrolase phage endolysin PlyCP41 in plants using virus-based systemic expression |
| Q33798817 | Prevalence, genetic diversity, and host range of tectiviruses among members of the Bacillus cereus group |
| Q42180232 | Quantitative analysis of the thermal stability of the gamma phage endolysin PlyG: a biophysical and kinetic approach to assaying therapeutic potential |
| Q47137352 | Revisiting Antibiotic Resistance Spreading in Wastewater Treatment Plants - Bacteriophages as a Much Neglected Potential Transmission Vehicle |
| Q28538904 | Structural and biochemical characterization reveals LysGH15 as an unprecedented "EF-hand-like" calcium-binding phage lysin |
| Q64896953 | Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus. |
| Q46230519 | Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice |
| Q24623471 | X-ray crystal structure of the streptococcal specific phage lysin PlyC. |
Search more.